National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Antimicrobial (Drug) Resistance
 Understanding Antimicrobial (Drug) Resistance
 Research
 Examples of Antimicrobial Resistance
  MRSA
  VRE
   Overview
   Transmission
   Diagnosis
   Treatment
   Prevention
   Research
   Frequently Asked Questions


Antimicrobial (Drug) Resistance

Vancomycin-Resistant Enterococci (VRE)

Prevention

Proper hand hygiene—thorough washing with soap and then drying—is the best way to prevent the spread of enterococci.

The CDC Hospital Infection Control Program encourages hospitals to develop their own institution-specific plans, which should stress

  • Prudent vancomycin use by clinicians
  • Hospital staff education regarding vancomycin resistance 
  • Early detection and prompt reporting of vancomycin resistance in enterococci and other gram-positive microorganisms by the hospital microbiology laboratory
  • Immediate implementation of appropriate infection control measures to prevent person-to-person VRE transmission
previous link Treatment | Index | Research next link

Volunteer for Clinical Studies

Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.

Related Links

View a list of links for more information about antimicrobial (drug) resistance.

E-mail Icon E-mail this page
Print Icon Print this page
Plug-ins and Viewers
To open PDFs on this page, download and install the Adobe Acrobat Reader.

Volunteer for Clinical Studies

Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.

Related Links

View a list of links for more information about antimicrobial (drug) resistance.